NDLI: The Hepatic Reductase Null (HRN<sup>™</sup>) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Please wait, while we are loading the content...

The Hepatic Reductase Null (HRN^™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Silver nanoparticles – wolves in sheep's clothing?

Metal toxicity and the p53 protein: an intimate relationship

Beyond a means of exposure: a new view of the mother in toxicology research

Autophagy as the effector and player in DNA damage response of cells to genotoxicants

Quantum dot induced cellular perturbations involving varying toxicity pathways

Eugenia uniflora leaves essential oil induces toxicity in Drosophila melanogaster: involvement of oxidative stress mechanisms

Reproductive toxicity and meiotic dysfunction following exposure to the pesticides Maneb, Diazinon and Fenarimol

Uptake of gold nanoparticles in primary human endothelial cells

New approaches to advance the use of genetic toxicology analyses for human health risk assessment

HBCD and PCBs enhance the cell migration and invasion of HepG2 via the PI3 K/Akt pathway

Bisphenol-A exposure alters memory consolidation and hippocampal CA1 spine formation through Wnt signaling in vivo and in vitro

In vitro screening of environmental chemicals identifies zearalenone as a novel substrate of the placental BCRP/ABCG2 transporter

Effect of diselenide administration in thioacetamide-induced acute neurological and hepatic failure in mice

Effects of benzo[a]pyrene on mouse germ cells: heritable DNA mutation, testicular cell hypomethylation and their interaction with nucleotide excision repair

Rescue of cells from apoptosis increases DNA repair in UVB exposed cells: implications for the DNA damage response

Euphorbia tirucalli aqueous extract induces cytotoxicity, genotoxicity and changes in antioxidant gene expression in human leukocytes

Back cover

Toxicology Research Vol - 4 Issue - 2

Toxicology Research Vol - 4 Issue - 1

Toxicology Research Vol -3

Toxicology Research Vol -2

Toxicology Research Vol -1

The Hepatic Reductase Null (HRN^™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Content Provider	Royal Society of Chemistry (RSC)
Author	Stiborová, Marie Henderson, Colin J. Arlt, Volker M. Phillips, David H. Wolf, C. Roland
Copyright Year	2015
Abstract	The cytochrome P450 (P450) superfamily consists of a large number of haem-containing mono-oxygenases that play a pivotal role in the metabolism of many drugs and carcinogens. A number of gene knockout and transgenic mice have been developed to study the role of specific P450 isoenzymes in xenobiotic metabolism, but the functional redundancy inevitably found in the P450 gene superfamily make it difficult to determine the in vivo role of these enzymes in xenobiotic metabolism as a whole. Over ten years ago the Hepatic Reductase Null (HRN™) model was developed to overcome these limitations. In these mice cytochrome P450 oxidoreductase (POR), the electron donor to P450 enzymes, is deleted specifically in hepatocytes, resulting in the loss of essentially all hepatic P450 function. While the HRN model uses an hepatocyte-specific albumin promoter to drive POR deletion during mouse development to adulthood, adult Reductase Conditional Null (RCN) mice are entirely normal with respect to POR (and thus P450 function) until hepatic POR deletion is driven via a CYP1A1 promoter which is induced by treatment with the polycyclic aromatic hydrocarbon 3-methylcholanthrene, essentially recapitulating the phenotype of the HRN mouse. The HRN and RCN models have been used to study the metabolism and genotoxicity of a variety of environmental carcinogens including benzo[a]pyrene, aristolochic acid, 3-nitrobenzanthrone and 2-amino-1-methyl-6-phenylimiazo[4,5-b]pyridine and the results obtained are summarized in this review. For example, investigations of BaP metabolism in the HRN and RCN mice revealed an apparent paradox, whereby hepatic P450 enzymes appeared to be more important for detoxification of BaP in vivo, despite being involved in its metabolic activation in vitro. Cytochrome b5 is a microsomal haemoprotein which provides electrons (from cytochrome b5 reductase) to P450 enzymes; however, its role in carcinogen metabolism is still enigmatic. Therefore, a mouse line was generated with a conditional hepatic deletion of cytochrome b5 (HBN, Hepatic cytochrome b5 Null) that was also crossed with HRN mice to create a double conditional mutant, HBRN (Hepatic cytochrome b5/P450 Reductase Null), in which both enzymes are deleted specifically in the liver. The combination of the HRN, RCN, HBN and HBRN models provide a powerful approach to study the P450-dependent metabolism and (geno)toxicity of environmental carcinogens.
Starting Page	548
Ending Page	562
Page Count	15
File Format	HTM / HTML PDF
ISSN	2045452X
Volume Number	4
Issue Number	3
Journal	Toxicology Research
DOI	10.1039/c4tx00116h
Language	English
Publisher	Royal Society of Chemistry
Access Restriction	Open
Subject Keyword	Cytochrome b5 HRN Oxidoreductase Polycyclic aromatic hydrocarbon Liver Genotoxicity Royal College of Nursing Gene Hepatocyte HBN Cytochrome P450, family 1, member A1 Carboxylic acid Hepatic Reductase Null Drug metabolism Cytochrome b5 reductase Paradox Methylcholanthrene Cytochrome P450 Redox Albumin Pyrene Carcinogen Phenotype 3-Nitrobenzanthrone Pyridine Hemeprotein Mutation RCN
Content Type	Text
Resource Type	Article
Subject	Health, Toxicology and Mutagenesis Toxicology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The Hepatic Reductase Null (HRN™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid

Cytochrome b ₅ impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b ₅ /P450 reductase null (HBRN) mice.

The environmental pollutant and carcinogen 3-nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in rat lung and kidney, thereby enhancing its own genotoxicity.

Hepatic cytochrome p450 reductase-null mice as an animal model to study electron transfer pathways in cholesterol synthesis and cyp2e1-mediated drug metabolism (2006).

Review The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice

Using 3D MCF-7 mammary spheroids to assess the genotoxicity of mixtures of the food-derived carcinogens benzo[a]pyrene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

The Hepatic Reductase Null (HRN^™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Similar Documents

The Hepatic Reductase Null (HRN™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid

Cytochrome b 5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b 5 /P450 reductase null (HBRN) mice.

The environmental pollutant and carcinogen 3-nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in rat lung and kidney, thereby enhancing its own genotoxicity.

Hepatic cytochrome p450 reductase-null mice as an animal model to study electron transfer pathways in cholesterol synthesis and cyp2e1-mediated drug metabolism (2006).

Review The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice

Using 3D MCF-7 mammary spheroids to assess the genotoxicity of mixtures of the food-derived carcinogens benzo[a]pyrene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

The Hepatic Reductase Null (HRN™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants

Cytochrome b ₅ impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b ₅ /P450 reductase null (HBRN) mice.

The Hepatic Reductase Null (HRN^™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants